This Article Full Text Full Text (PDF) Corrected PDF A correction has been published Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by An, W.-L. Articles by Pei, J.-J. Search for Related Content PubMed PubMed Citation Articles by An, W.-L. Articles by Pei, J.-J.

(American Journal of Pathology. 2003;163:591-607.)
© 2003 American Society for Investigative Pathology

Up-Regulation of Phosphorylated/Activated p70 S6 Kinase and Its Relationship to Neurofibrillary Pathology in Alzheimer’s Disease

Wen-Lin An^*, Richard F. Cowburn^*, Lin Li, Heiko Braak, Irina Alafuzoff, Khalid Iqbal^¶, Inge-Grundke Iqbal^¶, Bengt Winblad^* and Jin-Jing Pei^*

From the Division of Experimental Geriatrics,^* Karolinska Institutet, Neurotec, Novum, Huddinge, Sweden; the Department of Pharmacology, Xuan-Wu Hospital, Capital University of Medical Sciences, Beijing, PR China; the Department of Anatomy, J.W. Goethe University, Frankfurt, Germany; the Department of Neuroscience and Neurology, Section of Neuropathology, Kuopio University, Kuopio, Finland; New York State Institute for Basic Research in Developmental Disabilities, ^¶ Staten Island, New York

The ribosomal S6 protein kinase p70 S6 kinase is known for its role in modulating cell-cycle progression, cell size, and cell survival. In response to mitogen stimulation, p70 S6 kinase activation up-regulates ribosomal biosynthesis and enhances the translational capacity of the cell. In Alzheimer’s disease (AD), there is a marked increase in total tau protein in the form of abnormally hyperphosphorylated tau (PHF-tau) in neurons with neurofibrillary tangles (NFTs). In the present study, we investigated whether p70 S6 kinase activation is associated with PHF-tau accumulation in AD. By immunohistochemistry, we found that the levels of phosphorylated p70 S6 kinase (at Thr389 or at Thr421/Ser424) were increased in accordance with the progressive sequence of neurofibrillary changes according to Braak’s criteria. Confocal microscopy showed that in AD brain, phosphorylated p70 S6 kinase appeared especially in neurons that are known to later develop NFTs. This pattern of neurons showed dot-like structures of phosphorylated p70 S6 kinase and hyperphosphorylated tau, which partially correlated with rab5 (endosome marker), lamp-1 (lysosome marker), and ubiquitin (ubiquitin-proteasomal system marker). By indirect enzyme-linked immunosorbent assay, phosphorylated p70 S6 kinase (Thr389 or Thr421/Ser424), total tau, and PHF-tau were found to be significantly increased in AD brain as compared to control cases. The levels of total p70 S6 kinase and p70 S6 kinase phosphorylated at Thr421/Ser424 showed significant correlations with the levels of both total tau and PHF-tau. Regression analyses revealed a significant dependence of total tau or PHF-tau on p70 S6 kinase phosphorylated at Thr421/Ser424 rather than at Thr389. The levels of ribosomal protein S6 as well as the levels of markers for the proteolytic system were also significantly increased in AD as compared to control brain. Using a SH-SY5Y neuroblastoma cell model, we found that 100 µmol/L zinc sulfate could induce p70 S6 kinase phosphorylation and activation, in particular at Thr421/Ser424. This up-regulation of the activated kinase resulted in an increased expression and phosphorylation of tau. Pretreatment of cells with rapamycin (an inhibitor of FRAP/mTOR which is the immediate upstream kinase of the p70 S6 kinase) attenuated the effects induced by zinc. In primary cultured neurons of rat cortical cortex, zinc sulfate treatment could repeat p70 S6 kinase phosphorylation and activation at Thr421/Ser424, followed by increased expression and phosphorylation of tau. Taken together, these data suggest that activated p70 S6 kinase could mediate an up-regulation of tau translation. The partial co-localization of phosphorylated p70 S6 kinase with rab5, lamp-1 and ubiquitin, or PHF-tau with ubiquitin suggests that the activated proteolytic system might not be sufficient to degrade the over-produced and over-phosphorylated tau protein. A p70 S6 kinase modulated up-regulation of tau translation might contribute to PHF-tau accumulation in neurons with neurofibrillary changes.

This article has been cited by other articles:

				M. L. Steinhilb, D. Dias-Santagata, T. A. Fulga, D. L. Felch, and M. B. Feany Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo Mol. Biol. Cell, December 1, 2007; 18(12): 5060 - 5068. [Abstract] [Full Text] [PDF]

				C. A. Dickey, M. Yue, W.-L. Lin, D. W. Dickson, J. H. Dunmore, W. C. Lee, C. Zehr, G. West, S. Cao, A. M. K. Clark, et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci., June 28, 2006; 26(26): 6985 - 6996. [Abstract] [Full Text] [PDF]

				M. Paccalin, S. Pain-Barc, C. Pluchon, C. Paul, H. Bazin, R. Gil, and J. Hugon The Relation Between p70S6k Expression in Lymphocytes and the Decline of Cognitive Test Scores in Patients With Alzheimer Disease Arch Intern Med, November 14, 2005; 165(20): 2428 - 2429. [Full Text] [PDF]

				Q. Ding, W. R. Markesbery, Q. Chen, F. Li, and J. N. Keller Ribosome Dysfunction Is an Early Event in Alzheimer's Disease J. Neurosci., October 5, 2005; 25(40): 9171 - 9175. [Abstract] [Full Text] [PDF]

				H. Tanimukai, I. Grundke-Iqbal, and K. Iqbal Up-Regulation of Inhibitors of Protein Phosphatase-2A in Alzheimer's Disease Am. J. Pathol., June 1, 2005; 166(6): 1761 - 1771. [Abstract] [Full Text] [PDF]

				F. M. Harris, W. J. Brecht, Q. Xu, R. W. Mahley, and Y. Huang Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase: MODULATION BY ZINC J. Biol. Chem., October 22, 2004; 279(43): 44795 - 44801. [Abstract] [Full Text] [PDF]